masoprocol has been researched along with Atheroma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badimon, JJ; Bauriedel, G; Huber, K; Hutter, R; Kastl, SP; Katsaros, KM; Kaun, C; Maurer, G; Speidl, WS; Wojta, J | 1 |
1 other study(ies) available for masoprocol and Atheroma
Article | Year |
---|---|
The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro.
Topics: Cells, Cultured; Complement C5a; Coronary Vessels; Fluorescent Antibody Technique; Gene Expression; Humans; Immunohistochemistry; Macrophages; Masoprocol; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; NF-kappa B; Plaque, Atherosclerotic; Quinazolines; Receptor, Anaphylatoxin C5a; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factor AP-1 | 2011 |